Sound Group Collaborates With HKUST(GZ) To Cultivate AI Innovation Talent

Sound Group Collaborates With HKUST(GZ) To Cultivate AI Innovation Talent GlobeNewswire October 27, 2025 SINGAPORE, Oct. 27, 2025 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global AI-powered audio company, today announced that one of its subsidiaries has officially donated to establish the “HKUST(GZ) Information Hub – LIZHI Innovation […]

LifeMD, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – LFMD

LifeMD, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – LFMD GlobeNewswire October 27, 2025 LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) for violations of §§10(b)

Xcellerant Ventures and Jetstream Founder John Shufeldt Establish the John Shufeldt School of Medicine and Medical Engineering at Arizona State University

Xcellerant Ventures and Jetstream Venture Fund today celebrate the announcement of the John Shufeldt School of Medicine and Medical Engineering at Arizona State University (ASU), made possible through a transformational nine-figure gift from Dr. John Shufeldt. The new school, a central part of the ASU Health system, received preliminary accreditation from the Liaison Committee on

Best Parental Control App (2025): Qustodio Named Leading Parental Control Solution by Expert Consumers

Expert Consumers has named Qustodio the best parental control app of 2025, citing its powerful cross-platform features, recent innovations, and family-focused tools that support both safety and digital wellbeing. Best Parental Control App — Qustodio: recognized for delivering privacy-conscious, easy-to-use software that empowers families to manage screen time, track location, filter web content, and monitor

CTF Life Harnesses the CTF Group Ecosystem to Forge Strategic Alliances with Three Major Hospitals

CTF Life today announced the signing of a Memorandum of Understanding with Gleneagles Hospital Hong Kong ('Gleneagles'), CUHK Medical Centre ('CUHKMC'), and Hong Kong Baptist Hospital ('HKBH') to establish strategic partnerships. In a pioneering move, CTF Life has also become the first insurance company to collaborate with Gleneagles MediCentre in Admiralty to launch an exclusive

Investigation Launched into Netflix, Inc. (NFLX), Attorneys Encourage Investors and Potential Witnesses to Contact RGRD LLP

(NASDAQ:NFLX), SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Netflix, Inc. (NASDAQ: NFLX). If you have information that could assist in the Netflix investigation or if you are a Netflix investor who suffered a loss

Investigation Launched into Netflix, Inc. (NFLX), Attorneys Encourage Investors and Potential Witnesses to Contact RGRD LLP

Investigation Launched into Netflix, Inc. (NFLX), Attorneys Encourage Investors and Potential Witnesses to Contact RGRD LLP GlobeNewswire October 27, 2025 SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Netflix, Inc. (NASDAQ: NFLX). If you have

Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs

(Other OTC:KBLB),(OTC US:KBLB), ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced the promotion of Dr. Xiaoli Zhang to the position of Chief Scientist. This promotion follows a series of groundbreaking scientific achievements under Dr. Zhang's

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

(NASDAQ:ZBIO), – Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 – WALTHAM, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and

Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs

Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs GlobeNewswire October 27, 2025 ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced the promotion of Dr. Xiaoli Zhang to

Scroll to Top